Table 2 Characteristics of included citations
From: Towards understanding the de-adoption of low-value clinical practices: a scoping review
Characteristic | Number (%) of 109 citations |
|---|---|
Year of publication | |
1990–1999 | 3 (3) |
2000–2009 | 42 (38) |
2010–current | 64 (59) |
Country of origina | |
North America | 65 (60) |
Europe | 30 (28) |
Australasia | 22 (20) |
Type of article | |
Original research | 71 (65) |
Quasi-experimentalc | 30 (28) |
Cohort studyb | 15 (14) |
Mixed methods | 8 (7) |
Qualitative | 4 (4) |
Predictive modeling | 3 (3) |
Knowledge synthesis | 3 (3) |
Consensus method | 3 (3) |
Randomized clinical trial | 1 (1) |
Otherd | 6 (6) |
Non-original research | 38 (35) |
Editorial, letter to the editor, news item, other | 21 (19) |
Narrative review | 16 (15) |
Guideline | 1 (1) |
Focus of article | |
Identify low-value practices | 51 (47) |
Facilitate the de-adoption process | 44 (40) |
Evaluate de-adoption outcomes | 54 (50) |
Sustain de-adoption | 2 (2) |
Type of interventione | |
Therapeutic | 68 (62) |
Drug | 34 (31) |
Device or surgical procedure | 16 (15) |
Drugs and devices/procedures | 16 (15) |
Other | 3 (3) |
Diagnostic | 27 (30) |
Laboratory | 7 (8) |
Physiologic measurement | 4 (4) |
Diagnostic imaging | 3 (3) |
Screening program | 1 (1) |
Diagnostic tests not otherwise specified | 12 (13) |
Evidence to promote de-adoptionf | |
Randomized clinical trial | 45 (41) |
Knowledge synthesis | 14 (13) |
Clinical practice guideline | 6 (5) |
Cohort study | 4 (4) |
Quasi-experimentalc | 2 (2) |
Expert consensus | 2 (2) |
Reasons for de-adoptiong | |
Harm | 80 (73) |
Lack of efficacy | 69 (63) |
Not cost-effective | 37 (34) |